News Daily News Benefits of SGLT2 Inhibitors for HF Affirmed in Large, Real-world Study Todd Neale May 09, 2025
News Conference News EAS 2025 Back From the Brink: Obicetrapib Performs Well in BROADWAY, TANDEM Yael L. Maxwell May 08, 2025
News Daily News STRONG-HF Analysis Quantifies Gains From Rapid Uptake of GDMT Todd Neale May 08, 2025
News Conference News SCAI 2025 Medicare Analysis Reassures on PCI in Ambulatory Surgery Centers L.A. McKeown May 07, 2025
News Conference News HRS 2025 BIO-LIBRA: Outcomes Vary by Sex, Device in Cardiomyopathy Patients With ICDs Todd Neale May 02, 2025
News Conference News HRS 2025 CRT Patients Fare Better With LBB Area vs Biventricular Pacing Todd Neale April 30, 2025
News Conference News HRS 2025 VANISH2 Bolsters Data Backing VT Ablation in Ischemic Cardiomyopathy Todd Neale April 29, 2025
News Daily News TAVI and Complex/High-Risk PCI Safer if Staged, Registry Confirms Caitlin E. Cox April 28, 2025
News Conference News HRS 2025 GLP-1 Drugs May Have Role in Secondary Prevention of AF Todd Neale April 28, 2025
News Conference News HVS 2025 Solid Durability Seen With Surgical Resilia Tissue Aortic Valve Yael L. Maxwell April 21, 2025
News Daily News Weekend Warriors Also See Mortality Benefits With Exercise Michael O'Riordan April 10, 2025
News Conference News EHRA 2025 Post-TAVI Pacemaker Tied to Poorer Long-term Outcomes Todd Neale April 08, 2025
News Conference News ACC 2025 RIVAWAR: Rivaroxaban as Safe and Effective as Warfarin for LV Thrombus in MI Michael O'Riordan April 02, 2025
News Conference News ACC 2025 By 2 Years, Tricuspid TEER Reduces Hospitalizations for HF: TRILUMINATE Michael O'Riordan March 31, 2025
News Conference News EHRA 2025 Chronic HF Patients Needing CRT Fare Better With LBB Pacing: HeartSync-LBBP Todd Neale March 31, 2025
News Conference News ACC 2025 Evolut Low Risk Trial: TAVI Holds Up to Surgery at 5 Years L.A. McKeown March 30, 2025
News Conference News ACC 2025 More ALIGN-AR Data Bolster Potential for a Dedicated AR Device Yael L. Maxwell March 30, 2025
News Conference News ACC 2025 Dapagliflozin Works Well for High-Risk TAVI Patients With HF: DapaTAVI Caitlin E. Cox March 30, 2025